ArticleInterdisciplinary sciences, computational life sciences2026
CCVAN Leverages Conditional Molecular Generation Through Conditional VAE and Wasserstein GAN.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Molecular generation plays a vital role in advancing drug discovery, materials science, and chemical exploration. In this study, we integrated the conditional variational autoencoder (CVAE) with the Wasserstein generative adversarial network (WGAN) and effectively applied this hybrid architecture to molecular generation tasks, introducing a molecular generation framework with conditional generation capabilities known as CCVAN. The model first encodes the data into a latent vector using CVAE, then shares a decoder with the generator of the WGAN to reconstruct molecular SMILES, and trains the discriminator with both the generated and real molecular SMILES to achieve the goal of conditionally generating molecules. Compared to existing methods, CCVAN can generate molecules with specific properties as needed and performs well in terms of validity and novelty. In a case study, we utilized CCVAN for ligand-based and structure-based drug design, enabling the generation of high-binding-affinity molecules for target binding. Overall, the flexibility and effectiveness of CCVAN make it a valuable tool for accelerating the compound discovery process. The source code of CCVAN is publicly available at https://github.com/mjcoo/CCVAN .
Indexed as
Identifiers
42525178What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.